Micronics Gets $2.6M Grant for MDx Blood Screening | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Micronics today said that it has received a $2.6 million from the US Department of Defense to support development of its PanNAT system for point-of-care molecular diagnostics of infectious pathogens.

Redmond, Wash.-based Micronics is developing the sample-to-answer system for rapid disease detection. It said that the PanNAT system will directly detect multiple blood-borne pathogens, including hepatitis B and C and HIV, in fresh blood samples.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.